Differential susceptibility of inbred mouse strains to Burkholderia thailandensis aerosol infection

Microbial Pathogenesis

Volumn 48, Issue 1, 2010, Pages 9-17

  Morici, Lisa A ^a   Heang, Julie ^a   Tate, Tim ^a   Didier, Peter J ^b   Roy, Chad J ^a,b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

Aerosol infection; Burkholderia; TLR4

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BAGG ALBINO MOUSE; BURKHOLDERIA; BURKHOLDERIA INFECTION; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; C3H MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; FEMALE; INBRED STRAIN; INFECTION RESISTANCE; INFECTION SENSITIVITY; LETHALITY; LUNG INFECTION; MELIOIDOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STRAIN DIFFERENCE;

AEROSOLS; ANIMAL STRUCTURES; ANIMALS; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MELIOIDOSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMONIA, BACTERIAL; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTOR 4;

ANIMALIA; BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; MUS;

EID: 72149109282     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.10.004     Document Type: Article

References (39)

1. Wiersinga W.J., van der Poll T., White N.J., Day N.P., and Peacock S.J. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 4 4 (2006) 272-282
2. Dance D.A. Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 74 2-3 (2000) 159-168
3. Dance D.A. Burkholderia pseudomallei infections. Clin Infect Dis 30 1 (2000) 235-236
4. Stone R. Infectious disease. Racing to defuse a bacterial time bomb. Science 317 5841 (2007) 1022-1024
5. Brett P.J., Deshazer D., and Woods D.E. Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect 118 2 (1997) 137-148
6. Smith M.D., Angus B.J., Wuthiekanun V., and White N.J. Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect Immun 65 10 (1997) 4319-4321
7. Brett P.J., DeShazer D., and Woods D.E. Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like species. Int J Syst Bacteriol 48 Pt 1 (1998) 317-320
8. West T.E., Frevert C.W., Liggitt H.D., and Skerrett S.J. Inhalation of Burkholderia thailandensis results in lethal necrotizing pneumonia in mice: a surrogate model for pneumonic melioidosis. Trans R Soc Trop Med Hyg 102 Suppl. 1 (2008) S119-S126
9. Haraga A., West T.E., Brittnacher M.J., Skerrett S.J., and Miller S.I. Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei. Infect Immun 76 11 (2008) 5402-5411
10. Vial L., Lepine F., Milot S., Groleau M.C., Dekimpe V., Woods D.E., et al. Burkholderia pseudomallei, B. thailandensis, and B. ambifaria produce 4-hydroxy-2-alkylquinoline analogues with a methyl group at the 3 position that is required for quorum-sensing regulation. J Bacteriol 190 15 (2008) 5339-5352
11. Glass M.B., Gee J.E., Steigerwalt A.G., Cavuoti D., Barton T., Hardy R., et al. Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J Clin Microbiol 44 12 (2006) 4601-4604
12. Kim H.S., Schell M.A., Yu Y., Ulrich R.L., Sarria S.H., Nierman W.C., et al. Bacterial genome adaptation to niches: divergence of the potential virulence genes in three Burkholderia species of different survival strategies. BMC Genomics 6 (2005) 174
13. Atkins T., Prior R., Mack K., Russell P., Nelson M., Prior J., et al. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis. J Med Microbiol 51 7 (2002) 539-547
14. Wiersinga W.J., de Vos A.F., de Beer R., Wieland C.W., Roelofs J.J., Woods D.E., et al. Inflammation patterns induced by different Burkholderia species in mice. Cell Microbiol 10 1 (2008) 81-87
15. Harley V.S., Dance D.A., Drasar B.S., and Tovey G. Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Microbios 96 384 (1998) 71-93
16. Kespichayawattana W., Intachote P., Utaisincharoen P., and Sirisinha S. Virulent Burkholderia pseudomallei is more efficient than avirulent Burkholderia thailandensis in invasion of and adherence to cultured human epithelial cells. Microb Pathog 36 5 (2004) 287-292
17. Pongcharoen S., Niumsup P.R., and Butkhamchot P. Comparative study of interleukin-1beta expression by peripheral blood mononuclear cells and purified monocytes experimentally infected with Burkholderia pseudomallei and Burkholderia thailandensis. Immunol Invest 37 7 (2008) 704-713
18. Anuntagool N., Intachote P., Wuthiekanun V., White N.J., and Sirisinha S. Lipopolysaccharide from nonvirulent Ara+ Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates. Clin Diagn Lab Immunol 5 2 (1998) 225-229
19. Qazi O., Prior J.L., Judy B.M., Whitlock G.C., Kitto G.B., Torres A.G., et al. Sero-characterization of lipopolysaccharide from Burkholderia thailandensis. Trans R Soc Trop Med Hyg 102 Suppl. 1 (2008) S58-S60
20. Matsuura M., Kawahara K., Ezaki T., and Nakano M. Biological activities of lipopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. FEMS Microbiol Lett 137 1 (1996) 79-83
21. Utaisincharoen P., Tangthawornchaikul N., Kespichayawattana W., Anuntagool N., Chaisuriya P., and Sirisinha S. Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) in macrophages stimulated with Burkholderia pseudomallei endotoxin. Clin Exp Immunol 122 3 (2000) 324-329
22. West T.E., Ernst R.K., Jansson-Hutson M.J., and Skerrett S.J. Activation of Toll-like receptors by Burkholderia pseudomallei. BMC Immunol 9 (2008) 46
23. Wiersinga W.J., Wieland C.W., Dessing M.C., Chantratita N., Cheng A., Limmathurotsakul D., et al. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis). PLoS Med 4 7 (2007) e248
24. Cheng A.C., and Currie B.J. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18 2 (2005) 383-416
25. Skamene E., Gros P., Forget A., Kongshavn P.A., St Charles C., and Taylor B.A. Genetic regulation of resistance to intracellular pathogens. Nature 297 5866 (1982) 506-509
26. Titball R.W., Russell P., Cuccui J., Easton A., Haque A., Atkins T., et al. Burkholderia pseudomallei: animal models of infection. Trans R Soc Trop Med Hyg 102 Suppl. 1 (2008) S111-S116
27. Jeddeloh J.A., Fritz D.L., Waag D.M., Hartings J.M., and Andrews G.P. Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 71 1 (2003) 584-587
28. Leakey A.K., Ulett G.C., and Hirst R.G. BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb Pathog 24 5 (1998) 269-275
29. Liu B., Koo G.C., Yap E.H., Chua K.L., and Gan Y.H. Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun 70 2 (2002) 504-511
30. Stotland P.K., Radzioch D., and Stevenson M.M. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis. Pediatr Pulmonol 30 5 (2000) 413-424
31. Tan G.Y., Liu Y., Sivalingam S.P., Sim S.H., Wang D., Paucod J.C., de Boer A., Florquin S., Dondorp A., et al. Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice. J Med Microbiol 57 Pt 4 (2008) 508-515
32. Wiersinga W.J., Wieland C.W., van der Windt G.J., de Boer A., Florquin S., Dondorp A., et al. Endogenous interleukin-18 improves the early antimicrobial host response in severe melioidosis. Infect Immun 75 8 (2007) 3739-3746
33. Chen W., KuoLee R., Shen H., Busa M., and Conlan J.W. Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis. Microb Pathog 37 4 (2004) 185-191
34. Fremond C.M., Nicolle D.M., Torres D.S., and Quesniaux V.F. Control of Mycobacterium bovis BCG infection with increased inflammation in TLR4-deficient mice. Microbes Infect 5 12 (2003) 1070-1081
35. Abel B., Thieblemont N., Quesniaux V.J., Brown N., Mpagi J., Miyake K., et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 169 6 (2002) 3155-3162
36. Lettinga K.D., Florquin S., Speelman P., van Ketel R., van der Poll T., and Verbon A. Toll-like receptor 4 is not involved in host defense against pulmonary Legionella pneumophila infection in a mouse model. J Infect Dis 186 4 (2002) 570-573
37. Doz E., Rose S., Nigou J., Gilleron M., Puzo G., Erard F., et al. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan. J Biol Chem 282 36 (2007) 26014-26025
38. Smiley S.T. Immune defense against pneumonic plague. Immunol Rev 225 (2008) 256-271
39. Roy C.J., Warfield K.L., Welcher B.C., Gonzales R., Larsen T., Hanson J., et al. Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect Immun 73 4 (2005) 2452-2460